Cost-effectiveness in clinical trials: using multiple imputation to deal with incomplete cost data
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Background Cost-effectiveness has become an important outcome in many clinical trials and has resulted in the collection of resource use data and the calculation of costs for individual patients. A specific example is a Cancer Research UK phase III trial comparing chemotherapy (CT) against standard palliative care in patients with advanced non-small cell lung cancer. Resource usage from trial entry until death were collected and costs obtained on a subset of 115 trial patients. For some patients, however, the unavailability of medical notes resulted in some cost components, and hence total cost, being missing. The 82 patients with complete data were not representative of all trial patients in terms of effectiveness and thus it was necessary to address the missing data problem. Methods Multiple imputation (MI) was used to impute values for the unobserved individual cost components, allowing total cost to be calculated and cost-effectiveness carried out for all patients in the cost sub-study. The results are compared with those from a complete case analysis. Results After MI, the results indicated that CT had a high probability of being cost-effective for a societal willingness to pay over £20 000 per life-year gained. This was in stark contrast with the complete case analysis, which suggested that CT was not a cost-effective use of resources at any reasonable level of willingness to pay for a life-year. Limitations Our findings are based on a relatively small retrospective study with all events observed. Conclusion In conclusion, cost-effectiveness analysis of the complete cases only may give biased results, and therefore, in situations where there are missing costs, MI is recommended. Clinical Trials 2007; 4: 154—161. http://ctj.sagepub.com
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Missing data: our view of the state of the art
Schafer, J. L., & Graham, J. W. (2002) · Psychological Methods · doi:10.1037/1082-989x.7.2.147 · Cited by 11,638
Analysis of Incomplete Multivariate Data
Schafer, J. L. (1997) · doi:10.1201/9781439821862 · Cited by 6,012
Cited by
mice: Multivariate Imputation by Chained Equations in R
Buuren, S. V., & Groothuis-Oudshoorn, K. (2011) · Journal of Statistical Software · doi:10.18637/jss.v045.i03 · Cited by 13,870
“…et al. 2008; Thein et al. 2008; Garabed et al. 2008; Michel et al. 2009), genetics (Souverein et al. 2006), health economics (Briggs et al. 2003; Burton et al. 2007; Klein et al. 2008; Marshall et al. 2009), obesity and physical activity (Orsini et al. 2008a; Wiles et al. 2008; Orsini et al.…”
BackgroundMultiple imputation using chained equations: Issues and guidance for practice
White, I. R., Royston, P., & Wood, A. M. (2011) · Statistics in Medicine · doi:10.1002/sim.4067 · Cited by 9,792
“This approach has been applied to cost data [24].”
MethodSterne, J. A. C., White, I. R., Carlin, J. B., Spratt, M., Royston, P., Kenward, M. G., Wood, A. M., & Carpenter, J. R. (2009) · BMJ · doi:10.1136/bmj.b2393 · Cited by 7,299
Faria, R., Gomes, M., Epstein, D., & White, I. R. (2014) · PharmacoEconomics · doi:10.1007/s40273-014-0193-3 · Cited by 673
“The alternative approach is to draw bootstrap samples from each of the multiply imputed datasets and estimate the difference in net benefit between the treatment groups in each bootstrap sample (at a given threshold for cost per QALY) [30, 35].”
BackgroundNeelemaat, F., Bosmans, J. E., Thijs, A., Seidell, J. C., & van Bokhorst-de van der Schueren, M. A. E. (2012) · Clinical Nutrition · doi:10.1016/j.clnu.2011.10.009 · Cited by 84
Metadata
- Authors
- Burton, A., Billingham, L. J., & Bryan, S.
- Venue
- Clinical Trials
- Publisher
- SAGE Publications
- Published
- 2007-04
- Volume
- 4
- Issue
- 2
- Pages
- 154-161
- ISSN
- 1740-7745 (ISSN-L)
- 1740-7753
- OpenAlex
- W1966503507
- Cited by
- 137
- References
- 2
- FWCI
- 9.15
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Cost-effectiveness in clinical trials: using multiple imputation to deal with incomplete cost data. https://app.cochat.ai/papers/10.1177/1740774507076914
- The paper
- Burton, A., Billingham, L. J., & Bryan, S. (2007). Cost-effectiveness in clinical trials: using multiple imputation to deal with incomplete cost data. Clinical Trials. https://doi.org/10.1177/1740774507076914
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.